Raptor Pharmaceutical Corp. Announces Publication Of Results From Phase 2a Trial Of DR Cysteamine For Treatment Of Cystinosis
Links shared publicly online about this topic.
- 1,461total visits
Raptor Pharmaceutical Corp. Announces Publication Of Results From Phase 2a Trial Of DR Cysteamine For Treatment Of Cystinosis
Raptor Pharmaceutical Corp. (Raptor or the Company) (Nasdaq: RPTP), announced the publication of results from a Phase 2a clinical trial of a prototype formulation of its proprietary delayed-re
View full resource at medicalnewstoday.com
Tags: Pharma, Clinical Trial
Most Recently Shared on January 12, 2010 at 11:11 pm By:
Raptor Pharmaceutical Corp. Announces Publication Of Results From Phase 2a Trial Of DR Cysteamine For Treatment Of Cys... http://mnt.to/3w9k
Advertisement
